Physiological and pharmacological effects of estrogens in breast cancer
- PMID: 391285
- DOI: 10.1016/0304-419x(79)90012-x
Physiological and pharmacological effects of estrogens in breast cancer
Abstract
PIP: Focus here is on the mechanism of action of both estrogens and antiestrogens at the tumor cell levels in breast cancer. The interactions of estrogens and their antagonists are emphasized and analyzed in terms of current and potential clinical applications to breast cancer treatment. This review deals with these interrelationships at the molecular levels, not just with general aspects of endocrine interrelationships. The article is divided into 8 main parts: 1) an introduction, which reviews historical understanding of receptor technology and significances; 2) main properties of estrogens and estrogen receptors; 3) the influence of estrogens and antiestrogens on growth of experimental mammary tumor systems; 4) the suppression of or administration of estrogens for treatment of advanced human breast cancer; 5) estrogen receptivity of mammary tumors; 6) progress in treatment of advanced breast cancer derived from studies on the mode of action of estrogens; 7) the prognostic significance of estrogens and estrogenic receptivity (the estriol theory); and 8) concluding remarks on the future paths of receptor research.
Similar articles
-
Estrogen and progesterone receptor proteins in breast cancer.Biochim Biophys Acta. 1979 Dec 19;560(4):457-86. doi: 10.1016/0304-419x(79)90013-1. Biochim Biophys Acta. 1979. PMID: 391286 Clinical Trial.
-
Molecular basis of steroid hormone action in breast cancer and its clinical implications.Isr J Med Sci. 1981 Sep-Oct;17(9-10):954-9. Isr J Med Sci. 1981. PMID: 7031015 Review.
-
Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):191-200. doi: 10.1016/j.jsbmb.2004.12.002. Epub 2005 Jan 28. J Steroid Biochem Mol Biol. 2005. PMID: 15860262
-
The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.Clin Cancer Res. 2002 Jul;8(7):2378-88. Clin Cancer Res. 2002. PMID: 12114443
-
[Effects and mechanism of action of antiestrogens in breast cancer].Sem Hop. 1984 Mar 1;60(10):703-9. Sem Hop. 1984. PMID: 6322320 Review. French.
Cited by
-
Inhibition of environmental estrogen-induced proliferation of human breast carcinoma MCF-7 cells by flavonoids.In Vitro Cell Dev Biol Anim. 2001 May;37(5):275-82. doi: 10.1007/BF02577543. In Vitro Cell Dev Biol Anim. 2001. PMID: 11513082
-
Role of hormones in mammary cancer initiation and progression.J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):49-61. doi: 10.1023/a:1018770218022. J Mammary Gland Biol Neoplasia. 1998. PMID: 10819504 Review.
-
In vitro and in vivo interactions of methotrexate and other antimetabolites with the oestrogen high affinity receptors of the rat uterus.Br J Cancer. 1983 Mar;47(3):433-7. doi: 10.1038/bjc.1983.66. Br J Cancer. 1983. PMID: 6830693 Free PMC article. No abstract available.
-
Steroid receptor domain conformations and hormone antagonism.Naturwissenschaften. 1994 Mar;81(3):115-22. doi: 10.1007/BF01131766. Naturwissenschaften. 1994. PMID: 8183376 Review.
-
Early exposure to soy isoflavones and effects on reproductive health: a review of human and animal studies.Nutrients. 2010 Nov;2(11):1156-87. doi: 10.3390/nu2111156. Epub 2010 Nov 23. Nutrients. 2010. PMID: 22254003 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
